Market Approach

Multiples Through the Cycle: Rates, Region & Stage

The same company can be worth 10× revenue in one year and 4× the next, with no change to the business itself. If you treat a multiple as a fixed property of a sector, you will misprice across the cycle. Here is what actually moves it.

Written by Denis Voldman Head of Product, DealMatrixEdited by Philipp Sakuler Business Development, DealMatrixReviewed by Berthold Baurek-Karlic CEO, DealMatrixUpdated 10.06.2026
Investors tracking market cycles

A valuation multiple is not a constant. It is a price, and like any price it moves with supply, demand and the cost of money. Three forces dominate that movement: the macro cycle (above all, interest rates), the company’s stage, and its region. Understanding them is what separates a benchmark you can trust from a number that happened to be true once.

Interest rates and the macro cycle

The mechanism is direct. A company’s value is the present value of its future cash flows, discounted at a rate that rises and falls with prevailing interest rates. When rates are low, future cash flows are discounted gently, so they are worth more today, and multiples expand. When rates rise, the same cash flows are discounted harder, and multiples compress. Nothing about the business has changed; the denominator in everyone’s mental DCF has.

Illustrative effect of the rate environment
EnvironmentInterest ratesTypical multiple
Low-rate / boomLowHigh (8-12×)
High-rate / downturnHighLow (3-6×)

This is why the discipline of calibration matters so much: a multiple lifted from a deal in a different rate environment can be off by a factor of two, even if the comparable was otherwise perfect.

i

Capital availability amplifies the effect. Beyond the pure discount-rate mechanism, abundant capital in a boom bids multiples up further, while a funding drought forces them down. Investor sentiment is a real, measurable input, not noise to be ignored.

Stage: the same sector, priced differently by maturity

A pre-seed startup and a Series D scale-up in the same sector do not trade on the same multiple. Earlier-stage companies carry far higher growth expectations but also far higher risk and illiquidity. The net effect on the multiple is a balance of those two forces, and it shifts predictably as a company matures: growth premia fade, risk falls, and the multiple converges toward public-market levels.

Illustrative stage pattern (direction, not fixed values)
StageGrowth expectationRisk / illiquidityNet multiple effect
Pre-Seed / SeedVery highVery highGrowth premium dominates
Series A-BHighHighPeak relative multiple
Series C-DModeratingFallingConverging down
Pre-IPO / maturePublic-likeLowerNear public levels

For how this plays out across the funding journey, see How to Value a Startup, by Stage.

Region: structural valuation gaps between markets

Valuation levels differ systematically across regions, reflecting differences in capital depth, exit markets, risk appetite and currency. North America consistently commands the highest multiples; Europe trades at a structural discount; emerging markets discount further still. These gaps are persistent, not random, which is why a serious benchmark scales a multiple to the company’s actual region rather than applying a single global figure.

!

A multiple needs three coordinates. “EV/Sales of 6×” is incomplete. Six times revenue, for which stage, in which region, in which quarter? Strip any of those and the number stops being comparable.

How DealMatrix models all three at once

Adjusting for rates, stage and region by hand is error-prone. DealMatrix instead builds multiples through a six-step econometric framework that ingests roughly 200 public indices, cleans outliers, models the macro environment, then applies explicit regional and stage adjustments, refreshed every quarter so the benchmark always reflects current conditions, in line with IPEV 2025. The full mechanics are documented in the methodology.

Benchmarks that move with the market.

DealMatrix multiples are filtered by stage and region and recalibrated every quarter, so you are never pricing today’s deal on yesterday’s cycle.

See the Methodology →

Sources & further reading

  1. Damodaran, A. (2009). Valuing Young, Start-up and Growth Companies.
  2. IPEV (2025). International Private Equity and Venture Capital Valuation Guidelines.
  3. DealMatrix (2026). Multiples Methodology, data acquisition, cleaning, econometric modelling, regional & stage adjustment.

Continue in the guide

Key terms in this article